BioSpace News Archive

According to Report, the trauma implants market is estimated to expand growth at a CAGR of 6.9% from 2021 to 2031.

Surge in prevalence of cardiovascular disease, increase in aging population, and technological advancements are expected to raise the demand for vascular disease devices.

The swine flu vaccine is used to prevent the spread of H1N1 influenza that started as a pandemic in the year 2009.

Breckenridge Pharmaceutical, Inc. announces that it has launched Lacosamide Tablets, USP (generic version of Vimpat®).

Today, the U.S. Food and Drug Administration is warning the public of the risk of false results, inappropriate use and inappropriate interpretation of results with non-invasive prenatal screening (NIPS) tests, also called cell-free DNA tests or non-invasive prenatal tests (NIPT).

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2022 third quarter ended March 31, 2022, on Tuesday, May 10, 2022 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.

CONMED Corporation (NYSE: CNMD) today announced that it will reschedule the reporting of its first quarter 2022 financial results due to a corporate conflict.

Acerus Pharmaceuticals Corporation announced that the Company intends to undertake a consolidation of its outstanding common shares on the basis of one post-consolidation share for every two hundred pre-consolidation shares.

Evernorth, Cigna Corporation’s health services business, and Kaiser Permanente, one of the nation’s leading integrated health care organizations, announced a new, five-year collaboration aimed at delivering increased convenience, affordability and expanded access to high-quality care for Kaiser Permanente members.

Ocugen, Inc. announces that Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen, will present on-location at NobleCon18 - Noble Capital Markets’ Eighteenth Annual Investor Conference.